Eli Lilly LLY
NYSE LLY
$1,143.30 -6.79 (-0.59%)
At close: Oct 2, 2026 · 4:00 PM EDT

Eli Lilly (LLY) Selling, General & Administrative (2009 - 2026)

Updated

Eli Lilly (LLY) posted Selling, General & Administrative of $3.43 billion for Q2 2026, up 24.6% from $2.75 billion a year earlier and up 16.9% from the prior quarter.

Analysis

Eli Lilly (LLY) Selling, General & Administrative (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Eli Lilly was $12.24 billion, up 25.6% year-over-year; for FY2025, it came in at $11.09 billion, up 29.1% from FY2024.

  • Annual Selling, General & Administrative has increased for five consecutive years, with a five-year compound annual growth rate of 12.6% (FY2020 to FY2025).
  • In prior years, Eli Lilly's Selling, General & Administrative was $8.59 billion in FY2024 (+16.1%), $7.4 billion in FY2023 (+15.0%), $6.44 billion in FY2022 (+0.1%) and $6.43 billion in FY2021 (+5.1%).
  • The Q2 2026 figure stands as the highest quarterly Selling, General & Administrative in data going back to Q1 2009.
  • On a year-over-year basis, Selling, General & Administrative has increased in each of the last 16 quarters, with growth averaging 25.2% over the last eight quarters.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q3 2025, with growth of 30.5%; the weakest was Q2 2022, with a decline of 3.6%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $2.93 billion (Q1 2026), $3.13 billion (Q4 2025) and $2.74 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Vertex Pharmaceuticals 127.87 Bn 99.88 Bn 2.84 Bn 582.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.43 Bn
Mar 31, 2026 2.93 Bn
Dec 31, 2025 3.13 Bn
Sep 30, 2025 2.74 Bn
Jun 30, 2025 2.75 Bn
Mar 31, 2025 2.47 Bn
Dec 31, 2024 2.42 Bn
Sep 30, 2024 2.10 Bn
Jun 30, 2024 2.12 Bn
Mar 31, 2024 1.95 Bn
Dec 31, 2023 1.93 Bn
Sep 30, 2023 1.80 Bn
Jun 30, 2023 1.93 Bn
Mar 31, 2023 1.75 Bn
Dec 31, 2022 1.64 Bn
Sep 30, 2022 1.61 Bn
Jun 30, 2022 1.63 Bn
Mar 31, 2022 1.56 Bn
Dec 31, 2021 1.59 Bn
Sep 30, 2021 1.58 Bn
API Access

Eli Lilly Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=LLY&period=max&api_key=YOUR_API_KEY